Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-κB pathway in mice.

Q, Wang; Y, Ou; G, Hu; C, Wen; S, Yue; C, Chen; L, Xu; J, Xie; H, Dai; H, Xiao; Y, Zhang; R, Qi

doi:10.1111/bph.14938

Public

Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-κB pathway in mice.

Shared by NobleBlocks on Jan 30, 2020 • 12:00 AM UTC

Authors:

Wang Q

Ou Y

Hu G

Abstract

<h4>Background and purpose</h4>Naringenin, a flavonoid compound with strong anti-inflammatory activity, attenuated non-alcoholic fatty liver disease (NAFLD) induced by a methionine-choline deficient (MCD) diet in mice. However, the mechanisms underlying this suppression of inflammation and NAFLD rem...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!